Logo image of IVN.MI

IVISION TECH SPA (IVN.MI) Stock Fundamental Analysis

BIT:IVN - Euronext Milan - IT0005554784 - Common Stock - Currency: EUR

2.16  -0.16 (-6.9%)

Fundamental Rating

1

IVN gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 60 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of IVN have multiple concerns. IVN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

IVN had negative earnings in the past year.
In the past year IVN has reported a negative cash flow from operations.
IVN.MI Yearly Net Income VS EBIT VS OCF VS FCFIVN.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 -1M -2M -3M -4M

1.2 Ratios

IVN has a Return On Assets of -0.31%. This is comparable to the rest of the industry: IVN outperforms 47.27% of its industry peers.
Looking at the Return On Equity, with a value of -1.22%, IVN is in line with its industry, outperforming 47.27% of the companies in the same industry.
The Return On Invested Capital of IVN (1.80%) is comparable to the rest of the industry.
IVN had an Average Return On Invested Capital over the past 3 years of 3.57%. This is below the industry average of 7.96%.
Industry RankSector Rank
ROA -0.31%
ROE -1.22%
ROIC 1.8%
ROA(3y)1.01%
ROA(5y)N/A
ROE(3y)3.41%
ROE(5y)N/A
ROIC(3y)3.57%
ROIC(5y)N/A
IVN.MI Yearly ROA, ROE, ROICIVN.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2 4 6

1.3 Margins

IVN has a Operating Margin (4.57%) which is in line with its industry peers.
Looking at the Gross Margin, with a value of 60.12%, IVN is in line with its industry, outperforming 54.55% of the companies in the same industry.
Industry RankSector Rank
OM 4.57%
PM (TTM) N/A
GM 60.12%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IVN.MI Yearly Profit, Operating, Gross MarginsIVN.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 20 40 60 80

More info and screens

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IVN is destroying value.
Compared to 1 year ago, IVN has about the same amount of shares outstanding.
Compared to 1 year ago, IVN has a worse debt to assets ratio.
IVN.MI Yearly Shares OutstandingIVN.MI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2M 4M 6M
IVN.MI Yearly Total Debt VS Total AssetsIVN.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 5M 10M 15M

2.2 Solvency

Based on the Altman-Z score of 1.12, we must say that IVN is in the distress zone and has some risk of bankruptcy.
IVN's Altman-Z score of 1.12 is in line compared to the rest of the industry. IVN outperforms 43.64% of its industry peers.
A Debt/Equity ratio of 0.55 indicates that IVN is somewhat dependend on debt financing.
IVN's Debt to Equity ratio of 0.55 is in line compared to the rest of the industry. IVN outperforms 45.45% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF N/A
Altman-Z 1.12
ROIC/WACC0.25
WACC7.28%
IVN.MI Yearly LT Debt VS Equity VS FCFIVN.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 2M -2M 4M -4M 6M

2.3 Liquidity

A Current Ratio of 1.24 indicates that IVN should not have too much problems paying its short term obligations.
IVN has a Current ratio of 1.24. This is comparable to the rest of the industry: IVN outperforms 41.82% of its industry peers.
A Quick Ratio of 0.83 indicates that IVN may have some problems paying its short term obligations.
The Quick ratio of IVN (0.83) is worse than 61.82% of its industry peers.
Industry RankSector Rank
Current Ratio 1.24
Quick Ratio 0.83
IVN.MI Yearly Current Assets VS Current LiabilitesIVN.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2M 4M 6M

More info and screens

1

3. Growth

3.1 Past

IVN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -113.87%.
The Revenue has grown by 13.75% in the past year. This is quite good.
EPS 1Y (TTM)-113.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-99.49%
Revenue 1Y (TTM)13.75%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%21.51%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IVN.MI Yearly Revenue VS EstimatesIVN.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2M 4M 6M 8M
IVN.MI Yearly EPS VS EstimatesIVN.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IVN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IVN.MI Price Earnings VS Forward Price EarningsIVN.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IVN indicates a rather cheap valuation: IVN is cheaper than 89.09% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.54
IVN.MI Per share dataIVN.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for IVN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IVISION TECH SPA

BIT:IVN (3/7/2025, 7:00:00 PM)

2.16

-0.16 (-6.9%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.12%
Inst Owner ChangeN/A
Ins Owners66.68%
Ins Owner ChangeN/A
Market Cap16.85M
Analysts80
Price Target3.37 (56.02%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.63
P/FCF N/A
P/OCF N/A
P/B 2.52
P/tB 5.33
EV/EBITDA 10.54
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.37
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS1.32
BVpS0.86
TBVpS0.41
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.31%
ROE -1.22%
ROCE 3.27%
ROIC 1.8%
ROICexc 2.07%
ROICexgc 2.88%
OM 4.57%
PM (TTM) N/A
GM 60.12%
FCFM N/A
ROA(3y)1.01%
ROA(5y)N/A
ROE(3y)3.41%
ROE(5y)N/A
ROIC(3y)3.57%
ROIC(5y)N/A
ROICexc(3y)3.91%
ROICexc(5y)N/A
ROICexgc(3y)4.64%
ROICexgc(5y)N/A
ROCE(3y)6.48%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF N/A
Debt/EBITDA 1.59
Cap/Depr 113.9%
Cap/Sales 20.22%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.24
Quick Ratio 0.83
Altman-Z 1.12
F-Score1
WACC7.28%
ROIC/WACC0.25
Cap/Depr(3y)169.84%
Cap/Depr(5y)N/A
Cap/Sales(3y)42.64%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-113.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-99.49%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)13.75%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%21.51%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-60.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-22.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y358.36%
OCF growth 3YN/A
OCF growth 5YN/A